alfuzosin has been researched along with Hepatitis B, Chronic in 1 studies
alfuzosin: structure given in first source
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yolcu, OF | 1 |
| Köklü, S | 1 |
| Köksal, AS | 1 |
| Yüksel, O | 1 |
| Beyazit, Y | 1 |
| Basar, O | 1 |
1 other study available for alfuzosin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Alfuzosin-induced acute hepatitis in a patient with chronic liver disease.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged, 80 and over; Chemical and Drug Induced Liver Inju | 2004 |